HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$23.20
Day range
$22.73 - $25.14
Year range
$6.43 - $42.27
Market cap
1.10B USD
Avg Volume
972.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.50M | 41.81% |
Net income | -26.73M | -47.52% |
Net profit margin | — | — |
Earnings per share | -0.75 | — |
EBITDA | -29.24M | -42.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 260.45M | -22.52% |
Total assets | 285.50M | -17.51% |
Total liabilities | 21.98M | 138.63% |
Total equity | 263.51M | — |
Shares outstanding | 36.50M | — |
Price to book | 3.21 | — |
Return on assets | -25.10% | — |
Return on capital | -25.92% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.73M | -47.52% |
Cash from operations | -25.07M | -53.31% |
Cash from investing | 22.60M | 121.10% |
Cash from financing | -63.00K | -100.04% |
Net change in cash | -2.54M | -107.07% |
Free cash flow | -16.28M | -32.84% |
About
Founded
2022
Headquarters
Website
Employees
69
